$FOLD Headlines Apple

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2014 at 12:32 PM

$FOLD Headlines

Apple sets intraday record; PetSmart considers sale
1:56 p.m. Aug. 20, 2014
- Ben Eisen

Amicus Therapeutics shares up 25.6% in premarket trade
8:05 a.m. Aug. 20, 2014
- Ciara Linnane

Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial
8:04 a.m. Aug. 20, 2014
- Michael Calia

U.S. stocks rise as risk appetite returns
5:19 p.m. April 29, 2014
- Anora Mahmudova

Twitter rallies ahead of earnings; 3D Systems retreats
3:49 p.m. April 29, 2014
- Sue Chang

U.S. stock futures climb; House prices flat in February
9:19 a.m. April 29, 2014
- Barbara Kollmeyer

Amicus rallies 52% premarket after positive trial results
7:25 a.m. April 29, 2014
- Sara Sjolin

Amicus rallies 52% premarket after positive trial results
7:08 a.m. April 29, 2014
- Sara Sjolin

Amicus stock down after it delays seeking Fabry OK
10:44 a.m. June 17, 2013
- MarketWatch.com

Friday’s biggest gaining and declining stocks
10:45 a.m. Jan. 4, 2013
- Greg Morcroft

Amicus Therapeutics up 11% in premarket
8:52 a.m. Jan. 4, 2013
- Steve Gelsi

Thursday’s movers: Apple ends in red on price cut
6:03 p.m. Dec. 20, 2012
- Sue Chang

Amicus down 45% in premarket
9:44 a.m. Dec. 20, 2012
- Steve Gelsi

Amicus falls 47% in premarket trades
8:52 a.m. Dec. 20, 2012
- Steve Gelsi

Bed Bath shares hurt, Jabil climbs after hours
7:31 p.m. Dec. 19, 2012
- Carla Mozee

Amicus, GlaxoSmithKline say treatment misses goal
6:22 p.m. Dec. 19, 2012
- MarketWatch.com

Amicus Therapeutics shares tumble 49% after hours
5:45 p.m. Dec. 19, 2012
- Carla Mozee

U.S. Hot stocks to watch
7:28 a.m. July 18, 2012
- MarketWatch.com

U.S. may end patents on DNA: report
1:13 p.m. Oct. 30, 2010
- Christopher Hinton

Monday's biggest gaining and declining stocks
4:51 p.m. Oct. 5, 2009
- MarketWatch

3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus

1:25 p.m. Sept. 8, 2014
- benzinga.com

Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape

8:36 a.m. Sept. 3, 2014
- Zacks.com

InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical

10:13 a.m. Aug. 30, 2014
- Seeking Alpha

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

10:32 a.m. Aug. 27, 2014
- Zacks.com

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog

9:49 a.m. Aug. 27, 2014
- Zacks.com

The Biotech Stock With The Best One-Week Performance

2:46 p.m. Aug. 25, 2014
- benzinga.com

Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog

4:55 p.m. Aug. 21, 2014
- Zacks.com

Perilous Reversal Stock: Amicus Therapeutics (FOLD)

9:45 a.m. Aug. 21, 2014
- TheStreet.com

Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape

9:39 a.m. Aug. 21, 2014
- Zacks.com

Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape

9:03 a.m. Aug. 21, 2014
- Zacks.com

Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)

3:43 p.m. Aug. 20, 2014
- Seeking Alpha

Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today

10:29 a.m. Aug. 20, 2014
- TheStreet.com

Stocks Hitting 52-Week Highs

9:15 a.m. Aug. 20, 2014
- benzinga.com

Amicus Fabry disease drug candidate successful in Phase 3 trial

7:27 a.m. Aug. 20, 2014
- Seeking Alpha

Benzinga's Top #PreMarket Gainers

7:10 a.m. Aug. 20, 2014
- benzinga.com

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

6:01 a.m. Aug. 20, 2014
- TheStreet.com

Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript

9:37 p.m. Aug. 7, 2014
- Seeking Alpha

10-Q: AMICUS THERAPEUTICS INC
5:07 p.m. Aug. 7, 2014
- Edgar Online - (EDG = 10Q, 10K)

Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape

8:44 a.m. Aug. 6, 2014
- Zacks.com

Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape

11:11 a.m. July 29, 2014
- Zacks.com

Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics
8:40 a.m. Sept. 12, 2014
- PR Newswire - PRF

Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo
8:40 a.m. Aug. 25, 2014
- PR Newswire - PRF

Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
6:00 a.m. Aug. 20, 2014
- GlobeNewswire

Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics
8:50 a.m. Aug. 13, 2014
- PR Newswire - PRF

Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. Aug. 7, 2014
- GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
4:01 p.m. July 31, 2014
- GlobeNewswire

Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis
8:50 a.m. July 30, 2014
- PR Newswire - PRF

Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma
7:20 a.m. July 10, 2014
- PR Newswire - PRF

Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc.
2:55 p.m. July 7, 2014
- PR Newswire - PRF

Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array
6:30 a.m. July 3, 2014
- PR Newswire - PRF

Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012
7:00 a.m. June 30, 2014
- GlobeNewswire

Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum
8:20 a.m. June 4, 2014
- PR Newswire - PRF

Amicus Therapeutics to Present at UBS Global Healthcare Conference
4:10 p.m. May 14, 2014
- GlobeNewswire

Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. May 5, 2014
- GlobeNewswire

Dr. Farzad Mostashari to keynote SAS Health Analytics Executive
Conference
10:30 a.m. May 5, 2014
- BusinessWire - BZX

Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus
8:00 a.m. May 2, 2014
- PR Newswire - PRF

Amicus Therapeutics to Announce First Quarter 2014
10:01 a.m. May 1, 2014
- GlobeNewswire

Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics
8:00 a.m. April 30, 2014
- PR Newswire - PRF

Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011
6:01 a.m. April 29, 2014
- GlobeNewswire

Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference
4:39 p.m. March 27, 2014
- GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epsilor Launches Cutting-Edge 6T Battery for Military Use

A Big Leap for Military Power on the Go Seems like Epsilor just raised the stakes in the military tech race with their latest 6T battery, a piece of kit boasting some serious muscle at 4,400Wh with 174Ah thrown in for good measure. Serving up a military-grade solution where endurance and performance are necessities, they've entered production just in time for the...

Veteran Suicide Prevention: The Urgency Behind CVN's Push

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Hyperscale Recalibrates: AI Boom or Risky Bet?

Is Hyperscale Making the Right Move? Hyperscale Data, Inc. waved goodbye to the Bitcoin mining days to clear the stage for artificial intelligence (AI). But is this strategic leap off the blockchain and into AI territory as golden as promised? Whisper around the street is it could turn into a $3 billion windfall. But let's chew through the details before toasting...

UNISORB Expands Reach with BILZ Acquisition

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

AEC Firms Revamp Strategies Amid Talent Tug-of-War

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Lindian's Bold Leap into Rare Earths Processing

Changing the Game in Rare Earths When Lindian Resources announces a partnership, it's not just window dressing. This time, they've linked arms with Carester SAS for a hefty venture into oxide separation. The scope? An 8,000-tonne REO facility in Kazakhstan, a place already stamped as a geological treasure chest. We're staring at what could potentially be a new dawn for...

Empirik.ai's $21M for AI in Infrastructure Revolution

AI-Powered Infrastructure Takes the Stage Well, here's a tech gambit going full steam: empirik.ai just hit the digital scene with a $21 million war chest. Fresh out of the stealth shadows, they've got big names like Sequoia Capital, S32, Canapi Ventures, and Alumni Ventures stamping their ticket. What's the fuss? They're rolling out the first AI agent designed to...

ZPMC Names Two New 38,000 DWT Vessels for Chipolbrok

Navigating Uncharted Waters with New Vessels Some days, you see a giant leap in an industry and think, "Well, someone's got ambition." Here, we're talking about ZPMC's gutsy naming ceremony for two spanking new 38,000 DWT multipurpose heavy-lift ships destined for Chipolbrok, happening fresh off the docks in Shanghai. Specifications That Make Waves Imagine a vessel the...

BlueSky Enters Nashville: In-Home Vet Care Begins

Nashville Welcomes A New Wave of Pet Care In a world where convenience is king, BlueSky At-Home Veterinary Care is stepping up to the plate—or should I say, doorstep—by rolling out its fresh take on veterinary services in Nashville. Kicking off on September 15, 2026, this isn't just any ol' run-of-the-mill clinic opening. We're talking about vets coming straight to...

CGX Hits Big Stage with New Obstacle Racing Shoes

A Bold Step into Obstacle Racing Today, CGX is shaking things up in the world of obstacle racing. The Chinese footwear brand launched its CGX&OCR R1010 and R1020 shoes right at the UIPM 2026 Obstacle World Championships in Beijing. Talk about a grand entrance. Targeting high-stakes international competition, these shoes are set to redefine how athletes tackle those...